KRYS – Krystal Biotech, Inc.
KRYS — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
12.21
Margin Of Safety %
-18
Put/Call OI Ratio
0.26
EPS Next Q Diff
0.36
EPS Last/This Y
1.3
EPS This/Next Y
1.7
Price
318.27
Target Price
330.56
Analyst Recom
1.17
Performance Q
28.6
Upside
-17.7%
Beta
0.52
Ticker: KRYS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-18 | KRYS | 291.74 | 0.16 | 0.88 | 3031 |
| 2026-05-19 | KRYS | 293.66 | 0.19 | 0.26 | 3116 |
| 2026-05-20 | KRYS | 301.97 | 0.19 | 0.25 | 3122 |
| 2026-05-21 | KRYS | 304.38 | 0.19 | 5.00 | 3148 |
| 2026-05-22 | KRYS | 299.28 | 0.23 | 0.11 | 3249 |
| 2026-05-26 | KRYS | 302.66 | 0.23 | 0.06 | 3265 |
| 2026-05-27 | KRYS | 307.07 | 0.23 | 0.56 | 3269 |
| 2026-05-28 | KRYS | 310.64 | 0.23 | 2.70 | 3283 |
| 2026-05-29 | KRYS | 309.53 | 0.23 | 0.13 | 3297 |
| 2026-06-02 | KRYS | 293.61 | 0.24 | 1.07 | 3337 |
| 2026-06-03 | KRYS | 301.54 | 0.27 | 0.11 | 3492 |
| 2026-06-04 | KRYS | 308.04 | 0.27 | 0.30 | 3519 |
| 2026-06-05 | KRYS | 300.4 | 0.27 | 0.13 | 3526 |
| 2026-06-08 | KRYS | 301.65 | 0.26 | 1.25 | 3544 |
| 2026-06-09 | KRYS | 309.8 | 0.26 | 0.75 | 3540 |
| 2026-06-10 | KRYS | 312.62 | 0.26 | 0.22 | 3543 |
| 2026-06-11 | KRYS | 321.25 | 0.26 | 0.22 | 3559 |
| 2026-06-12 | KRYS | 318.3 | 0.26 | 0.10 | 3740 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-18 | KRYS | 291.24 | 50.5 | 29.7 | 8.38 |
| 2026-05-19 | KRYS | 293.30 | 50.5 | 43.3 | 8.38 |
| 2026-05-20 | KRYS | 302.04 | 50.5 | 48.5 | 8.38 |
| 2026-05-21 | KRYS | 304.29 | 50.5 | 43.4 | 8.38 |
| 2026-05-22 | KRYS | 299.26 | 50.5 | 37.5 | 8.38 |
| 2026-05-26 | KRYS | 302.85 | 53.9 | 44.4 | 8.55 |
| 2026-05-27 | KRYS | 307.07 | 53.9 | 44.9 | 8.55 |
| 2026-05-28 | KRYS | 310.40 | 50.5 | 44.5 | 8.38 |
| 2026-05-29 | KRYS | 309.32 | 50.5 | 40.7 | 8.38 |
| 2026-06-01 | KRYS | 298.32 | 50.5 | 32.8 | 8.38 |
| 2026-06-02 | KRYS | 292.86 | 50.5 | 37.1 | 8.38 |
| 2026-06-03 | KRYS | 301.74 | 50.5 | 48.6 | 8.38 |
| 2026-06-04 | KRYS | 307.49 | 50.5 | 46.2 | 8.38 |
| 2026-06-05 | KRYS | 300.76 | 50.5 | 35.8 | 8.38 |
| 2026-06-08 | KRYS | 302.33 | 50.5 | 42.9 | 8.38 |
| 2026-06-09 | KRYS | 309.61 | 50.5 | 47.9 | 8.38 |
| 2026-06-10 | KRYS | 312.39 | 50.5 | 43.9 | 8.38 |
| 2026-06-11 | KRYS | 321.24 | 50.5 | 48.2 | 8.38 |
| 2026-06-12 | KRYS | 318.27 | 50.5 | 39.3 | 8.38 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-18 | KRYS | -6.18 | -1.99 | 12.06 |
| 2026-05-19 | KRYS | -6.24 | -1.99 | 12.06 |
| 2026-05-20 | KRYS | -6.24 | -1.99 | 12.06 |
| 2026-05-21 | KRYS | -6.24 | -1.99 | 12.06 |
| 2026-05-22 | KRYS | -6.24 | -1.99 | 12.06 |
| 2026-05-26 | KRYS | -6.24 | -0.76 | 12.04 |
| 2026-05-27 | KRYS | -6.33 | -0.76 | 12.04 |
| 2026-05-28 | KRYS | -6.35 | -0.76 | 12.38 |
| 2026-05-29 | KRYS | -6.35 | -0.76 | 12.38 |
| 2026-06-02 | KRYS | -6.35 | -1.27 | 12.38 |
| 2026-06-03 | KRYS | -6.35 | -1.27 | 12.38 |
| 2026-06-04 | KRYS | -6.35 | -1.27 | 12.38 |
| 2026-06-05 | KRYS | -6.35 | -1.27 | 12.38 |
| 2026-06-08 | KRYS | -5.17 | -1.27 | 12.38 |
| 2026-06-09 | KRYS | -5.17 | -1.27 | 12.38 |
| 2026-06-10 | KRYS | -5.17 | -1.27 | 12.24 |
| 2026-06-11 | KRYS | -5.17 | -1.27 | 12.24 |
| 2026-06-12 | KRYS | -5.24 | -1.27 | 12.21 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.83
Avg. EPS Est. Current Quarter
1.94
Avg. EPS Est. Next Quarter
2.19
Insider Transactions
-5.24
Institutional Transactions
-1.27
Beta
0.52
Average Sales Estimate Current Quarter
125
Average Sales Estimate Next Quarter
137
Fair Value
260.13
Quality Score
90
Growth Score
39
Sentiment Score
98
Actual DrawDown %
2.5
Max Drawdown 5-Year %
-44.5
Target Price
330.56
P/E
42.5
Forward P/E
32.74
PEG
1.42
P/S
22.46
P/B
7.33
P/Free Cash Flow
39.49
EPS
7.48
Average EPS Est. Cur. Y
8.38
EPS Next Y. (Est.)
10.08
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
53.92
Relative Volume
1.02
Return on Equity vs Sector %
-10
Return on Equity vs Industry %
6.4
EPS 1 7Days Diff
EPS 1 30Days Diff
0.8
EBIT Estimation
39.3
◆
KRYS
Healthcare
$317.97
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
61.6
Range 1M
73.2%
Sup Dist
1.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
13.3%
EPS NY
25.3%
52W%
93.9%
Long-Term Value
Quality companies, undervalued
WATCH
🟡 HOLD
+0.8% upside
Upside
+0.8%
Quality
90
MoS
-18%
Krystal Biotech, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 295
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
KRYS
Latest News
—
Caricamento notizie per KRYS…
stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today
news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance
stock history KRYS – Krystal Biotech, Inc. invest stock market
stock prices KRYS premarket after hours
ticker KRYS fair value insiders trading